pSivida Limited Signs Evaluation Agreement for Cardiovascular Drug Delivery

BOSTON & PERTH, Australia--(BUSINESS WIRE)--Global drug delivery company, pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) announced that it has entered into an evaluation agreement with an undisclosed large global medical device company to evaluate cardiovascular delivery of drugs using pSivida’s drug delivery technologies. The agreement follows the expiration of a previous evaluation agreement with the same medical device company.

MORE ON THIS TOPIC